Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...